Clinical efficacy and nocebo effect following non-medical biosimilar switch in patients with inflammatory bowel disease: A prospective observational study

We aimed to evaluate clinical efficacy, biomarker activity, therapeutic drug monitoring (TDM), adverse events (AEs), and nocebo effect in inflammatory bowel disease (IBD) patients who underwent non-medical biosimilar switching.

Source: Digestive and Liver Disease - July 5, 2023 Category: Gastroenterology Authors: Panu Wetwittayakhlang, Khaled Karkout, Arti Wongcha-um, Paraskevi Tselekouni, Reem Al-Jabri, Waqqas Afif, Gary Wild, Alain Bitton, Talat Bessissow, Peter L. Lakatos Tags: Alimentary Tract Source Type: research